Tateyama, Chiba Prefecture, Japan Related Funds
| Fund Name | Location |
| ACG Qingbao She | - |
| Belden | Missouri, St Louis, United States |
| Concrete Rose Capital | California, San Francisco, United States |
| Conrad Labs | Lahore, Pakistan, Punjab |
| Crayhill Capital Management | New York, New York, United States |
| Creation Venture Partners | Chaoyang, China, Liaoning |
| Crowd Capital Ventures LLC | Florida, Miami, United States |
| ET Capital Partners | California, Pleasanton, United States |
| Harbor Street Ventures | Chicago, Illinois, United States |
| HEM ANGELS | India, Maharashtra, Mumbai |
| Jim Simons | - |
| JSTV.com | China, Jiangsu, Nanjing |
| Maven Ventures | California, Palo Alto, United States |
| Merstal Ltd. | - |
| National Education Association | District of Columbia, United States, Washington |
| Newchip | Austin, Texas, United States |
| Prospect Venture Partners | California, Palo Alto, United States |
| Unshackled Ventures | California, Palo Alto, United States |
| Wix Capital | Israel, Tel Aviv, Tel Aviv District |
| Xinyu Yueyun | China, Jiangxi, Xinyu |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CureApp | $20M | 05 Jul 2019 | Chiyoda, Japan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CureApp | $20M | 05 Jul 2019 | Chiyoda, Japan |
